Careers  |  Media  |  Contact us

RET mutation analysis (Exons 5, 8, 10, 11, 13, 14, 15, 16

Test Name

RET mutation analysis (Exons 5, 8, 10, 11, 13, 14, 15, 16

Home Collection, Lab Visit

Test Code

R0033

Test Components/ Genes/ Parameters

RET

Sample Report

Click on Icon

Test Information

TAT DETAILS

14 days

PRE-TEST INSTRUCTIONS

Submit formalin fixed paraffin embedded Tissue Block. Ship at room temperature

CLINICAL UTILITY

To rule out RET mutation in NSCLC patients to provide specific drugs that targets or inhibit RET. Currently selpercatinib and pralsetinib are the two approved RET-inhibitors

SPECIMEN STABILITY

Transport at ambient (18-25°C) temperature

METHODOLOGY

NGS

STORAGE TEMPERATURE

NA

SPECIMEN TYPE

Surgical tissue/Tissue Block

Frequently Asked Questions

RET mutation analysis (Exons 5, 8, 10, 11, 13, 14, 15, 16
It diagnose the RET mutation in NSCLC patient
The patient should carry the FFPE tissue or block of the Lung. This process is carried out by Breast Surgeon in the hospital
The test is recommended in adenocarcinoma of NSCLC
The test is performed by NGS technique
There is no risk associated with the test as biopsy will be taken by the trained surgeon in the hospital under anasthesia
The test report comes as RET mutation( Exons 5, 8, 10, 11, 13, 14, 15, 16) positive or negative